US 7,514,084 B2
	KDR peptides and vaccines comprising the same
Hideaki Tahara, Meguro-ku (Japan); Satoshi Wada, Meguro-ku (Japan); and Takuya Tsunoda, Minato-ku (Japan)
Assigned to Oncotherapy Science, Inc., Kanagawa (Japan)
Appl. No. 10/527,496 PCT Filed Sep. 12, 2003, PCT No. PCT/JP03/11722 § 371(c)(1), (2), (4) Date Feb. 13, 2006, PCT Pub. No. WO2004/024766, PCT Pub. Date Mar. 25, 2004.
Claims priority of application No. 2002-267285 (JP), filed on Sep. 12, 2002; application No. 2003-062003 (JP), filed on Mar. 07, 2003; and application No. 2003-167042 (JP), filed on Jun. 11, 2003.
Prior Publication US 2006/0216301 A1, Sep. 28, 2006
Int. Cl. A61K 39/00 (2006.01); A61K 38/08 (2006.01)

U.S. Cl. 424—185.1  [530/328]

10 Claims

1. An isolated nonapeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 30, and SEQ ID NO: 54, wherein zero, one or two amino acids have been substituted, wherein the nonapeptide binds to an HLA-A 0201 restricted T cell receptor with high affinity and induces a high CTL response.